Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 39.1B | 43.6B | 37.7B | 35.5B |
Cost of revenue | 14.1B | 14.7B | 13.6B | 11.8B |
Gross profit | 25.1B | 28.8B | 24.1B | 23.6B |
Operating expense | ||||
Research & development | -346M | 7.4B | -341M | -444M |
Selling general and admin | — | — | — | — |
Other operating expenses | 9.9B | -11.5B | 9.6B | 9.8B |
Operating income | 2.9B | 7.9B | 3.3B | 2.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 2.8B | 2.0B | 2.2B | 2.3B |
Other income expense | — | — | — | — |
Pretax income | 969M | 4.9B | 1.6B | 984M |
Tax provision | 77M | 274M | 748M | 713M |
Net income | 892M | 4.6B | 811M | 271M |
Basic EPS | 0.3 | — | 0.2 | -0.1 |
Diluted EPS | 0.3 | — | 0.2 | -0.1 |
Basic average shares | 1.2B | — | 1.2B | 1.2B |
Diluted average shares | 1.2B | — | 1.2B | 1.2B |
EBITDA | 8.3B | 1.0B | 7.9B | 7.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | -578M | -1.1B | -560M | -431M |
Preferred stock dividends | 0 | 0 | 0 | 0 |